Novartis Institutes for BioMedical Research Inc. 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-22 4:59 pm Sale |
2021-01-21 | 13D | Intellia Therapeutics, Inc. NTLA |
Novartis Institutes for BioMedical Research Inc. | 2,176,148 3.700% |
-2,176,147 (-50.00%) |
Filing |
| 2020-08-20 4:30 pm Unchanged |
2020-08-06 | 13D | Intellia Therapeutics, Inc. NTLA |
Novartis Institutes for BioMedical Research Inc. | 4,352,295 7.400% |
0 (Unchanged) |
Filing |